lenalidomide has been researched along with mesalamine in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (mesalamine) | Trials (mesalamine) | Recent Studies (post-2010) (mesalamine) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 3,906 | 540 | 1,579 |
| Protein | Taxonomy | lenalidomide (IC50) | mesalamine (IC50) |
|---|---|---|---|
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | 1.3007 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 7.73 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 7.53 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 0.28 | |
| 60 kDa chaperonin | Escherichia coli | 3.245 | |
| 10 kDa chaperonin | Escherichia coli | 3.245 | |
| Hydroxyacid oxidase 1 | Mus musculus (house mouse) | 7.8 | |
| large T antigen | Betapolyomavirus macacae | 19.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banskota, S; Jang, H; Jeong, BS; Kang, HE; Karmacharya, U; Kim, DG; Kim, JA; Nam, TG; Park, SW | 1 |
1 review(s) available for lenalidomide and mesalamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for lenalidomide and mesalamine
| Article | Year |
|---|---|
In vitro and in vivo inhibitory activity of 6-amino-2,4,5-trimethylpyridin-3-ols against inflammatory bowel disease.
Topics: Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Pyridines | 2016 |